M. Berg

发表

Long-term treatment with responsive brain stimulation in adults with refractory partial seizures

S. Cash, A. Murro, G. Worrell, 2015, Neurology.

Brain‐responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy

S. Cash, K. Meador, R. Goodman, 2017, Epilepsia.

Generic substitution in the treatment of epilepsy: Patient and physician perceptions

R. Gross, M. Berg, K. Tomaszewski, 2008, Epilepsy & Behavior.

Failure of standard magnetic resonance imaging in patients with refractory temporal lobe epilepsy.

G. Erba, W. Pilcher, M. Berg, 1998, Archives of neurology.

The transient syndrome of headache with neurologic deficits and CSF lymphocytosis

L. Williams, M. Berg, L. Williams, 1995, Neurology.

The place of generic modified-release formulations for epilepsy

J. French, M. Berg, 2016, Neurology.

Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype

Dean Y. Li, K. Whitehead, M. Berg, 2010, The FEBS journal.

Pseudoprogression of Cerebral Cavernous Angiomas: The Importance of Proper Magnetic Resonance Imaging Technique

L. Ketonen, L. Valanne, M. Berg, 1996, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial

J. Szaflarski, B. Dworetzky, J. Pollard, 2016, The Lancet Neurology.

Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.

D. Corcoran, R. Shenkar, I. Awad, 2014, Human molecular genetics.

Generic substitution in the treatment of epilepsy

R. Gross, M. Berg, K. Tomaszewski, 2008, Neurology.

Mutational analysis of 206 families with cavernous malformations.

Johnson, K., Faheem Niazi, 2003, Journal of neurosurgery.

Ictal Contralateral Paresis in Complex Partial Seizures

J. Burchfiel, G. Erba, M. Berg, 1995, Epilepsia.

Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27.

R. Scott, C. Ogilvy, I. Awad, 1998, Human molecular genetics.

Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy

S. Cash, B. Lundstrom, G. Mckhann, 2020, Neurology.

Deletions in CCM2 are a common cause of cerebral cavernous malformations.

C. Liquori, D. Marchuk, L. Ptáček, 2007, American journal of human genetics.

Genetic and neuroradiological heterogeneity of double cortex syndrome

I. Scheffer, C. Walsh, P. Huttenlocher, 2000, Annals of neurology.

Brain‐responsive neurostimulation in patients with medically intractable seizures arising from eloquent and other neocortical areas

Daniel Yoshor, Sydney S Cash, Gregory A Worrell, 2017, Epilepsia.

Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.

C. Liquori, D. Verlaan, A. Siegel, 2003, American journal of human genetics.

Hemorrhage From Cavernous Malformations of the Brain: Definition and Reporting Standards

L. Morrison, I. Awad, R. Al‐Shahi Salman, 2008, Stroke.

Allergies to multiple antiseizure medications: A relationship to ANA and SSA

G. Erba, M. Berg, M. Mcbride, 1999, Neurology.

Random-Effects Linear Modeling and Sample Size Tables for Two Special Crossover Designs of Average Bioequivalence Studies: The Four-Period, Two-Sequence, Two-Formulation and Six-Period, Three-Sequence, Three-Formulation Designs

Ron Krebill, Francisco J Diaz, Michel J Berg, 2013, Clinical Pharmacokinetics.

Extreme spindles: A distinctive EEG pattern in Mycoplasma pneumoniae encephalitis

C. Heatwole, M. Berg, J. Henry, 2005, Neurology.

Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus

C. Liquori, D. Marchuk, L. Ptáček, 2006, Human mutation.

Clinical Reasoning: Cerebral cavernous malformations

L. Chahine, M. Berg, 2009, Neurology.

Benign MRI findings and their pathologic mimics

M. Berg, C. Meyers, 2013, Neurology. Clinical practice.

Lateralization of mesial temporal lobe epilepsy with chronic ambulatory electrocorticography

Gregory A Worrell, Michael R Sperling, Robert E Wharen, 2015, Epilepsia.

Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial

J. Szaflarski, B. Dworetzky, J. Pollard, 2017, JAMA neurology.

IGF-1 Partially Restores Chemotherapy-Induced Reductions in Neural Cell Proliferation in Adult C57BL/6 Mice

M. J. Gallagher, Bryan D. Thompson, P. Jean-Pierre, 2010, Cancer investigation.

Long-termtreatmentwithresponsivebrain stimulationinadultswithrefractorypartial seizures

S. Cash, A. Murro, G. Worrell, 2015 .

Letter re: Clinical Reasoning: A young woman with respiratory failure, hearing loss, and paraplegia

M. Berg, 2017, Neurology.

SWAN MRI revealing multiple microhemorrhages secondary to septic emboli from mucormycosis

M. Berg, G. Yeaney, Michele A. Scully, 2012, Neurology.

Coffee and cigarette smoking interactions with lamotrigine

J. Szaflarski, M. Privitera, T. Welty, 2021, Epilepsy & Behavior.

What’s the problem with generic antiepileptic drugs?

M. Berg, 2007, Neurology.

Periventricular Heterotopia: An X-Linked Dominant Epilepsy Locus Causing Aberrant Cerebral Cortical Development

I. Scheffer, C. Walsh, P. Huttenlocher, 1996, Neuron.

Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females.

N W Wood, F Andermann, S M Sisodiya, 2001, Human molecular genetics.

How Do Clinicians Adjust Lamotrigine Doses and Use Lamotrigine Blood Levels?—A Q-PULSE Survey

J. Pollard, M. Privitera, T. Welty, 2014, Epilepsy currents.

Cavernous Malformations of the Nervous System: Clinical features and medical management of cavernous malformations

M. Berg, Tegan Vay, 2011 .